Australian Firms Face Higher PBS Fees As Govt Seeks To Cover Assessment Costs
Executive Summary
Australian pharmaceutical companies are facing possible increases in the fees they have to pay for applications to have medicines listed on the Pharmaceutical Benefits Scheme, as the government proceeds with plans to ensure fee revenues cover the full cost of assessment work.